Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Chemoinformatics Market: By Application, By Tool, By End User, and Geography
Chemoinformatics Market: By Application, By Tool, By End User, and Geography
Chemoinformatics Market size was valued at US$ 5,921.3 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 16.3% from 2024 to 2030. Chemoinformatics represents a multidisciplinary field that combines chemistry, biology, and computer science to streamline drug discovery and chemical analysis processes. This market encompasses various tools and technologies essential for storing, processing, and analyzing chemical and biological data, including chemical databases, molecular modeling software, and quantitative structure-activity relationship (QSAR) tools.
The chemoinformatics market serves a diverse range of applications, from early-stage drug discovery to materials science and environmental research. The growth of the chemoinformatics market is driven by factors such as the increasing demand for efficient drug discovery processes, advancements in artificial intelligence and machine learning, and the rising adoption of in silico methods in research. For instance, according to a report by the Tufts Center for the Study of Drug Development, the use of AI in drug discovery can potentially reduce early drug discovery timelines by 3-5 years and cut costs by 30-50%. Moreover, the COVID-19 pandemic has accelerated the adoption of computational methods in drug research, further boosting market expansion. However, challenges such as data standardization issues, the need for skilled professionals, and concerns about data security may impact market growth to some extent.
Study Period
2024-2030Base Year
2023CAGR
16.3%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The increasing pressure to reduce drug discovery timelines and costs, coupled with the growing complexity of target diseases, has intensified the demand for advanced computational tools in chemistry and biology. Chemoinformatics offers several advantages over traditional methods, including rapid virtual screening of large compound libraries, prediction of drug-like properties, and optimization of lead compounds. These factors contribute to the expanding adoption of chemoinformatics tools across the pharmaceutical and biotechnology industries.
Furthermore, technological advancements in artificial intelligence, machine learning, and quantum computing have enhanced the capabilities of chemoinformatics platforms. The development of improved algorithms for molecular docking, de novo drug design, and retrosynthesis prediction has addressed many historical challenges associated with computational chemistry. Additionally, the shift towards precision medicine and the emphasis on rational drug design have favored the growth of chemoinformatics approaches, particularly in target identification and lead optimization. This trend has been further accelerated by the success of AI-driven drug discovery projects, which have demonstrated the potential to significantly reduce the time and cost of bringing new drugs to market.
In 2023, North America accounted for the largest revenue share in the chemoinformatics market. The region's dominance is attributed to the presence of major pharmaceutical and biotechnology companies, substantial investment in R&D, and early adoption of advanced computational technologies. The United States, in particular, has seen significant advancements in chemoinformatics research and development, supported by initiatives like the NIH's Big Data to Knowledge (BD2K) program. The Asia-Pacific region is expected to witness the most rapid growth in the chemoinformatics market. This expansion is fuelled by increasing government support for life sciences research, growing pharmaceutical and biotechnology sectors, and rising adoption of AI and machine learning technologies. Countries like China, Japan, and India are investing heavily in computational chemistry and drug discovery capabilities, driving the demand for chemoinformatics tools and services.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 5,921.3 million |
|
Market CAGR |
16.3% |
|
By Application |
|
|
By Tool |
|
|
By End User |
|
Download Free Sample Report
Chemoinformatics Market size was valued at US$ 5,921.3 million in 2023
The expansion of the chemoinformatics market is driven by the increasing demand for efficient drug discovery processes, advancements in AI and machine learning, rising adoption of in silico methods, and the growing complexity of target diseases.
Data standardization issues, the need for skilled professionals, and concerns about data security and intellectual property protection may hamper the global chemoinformatics market. The high cost of advanced software tools and the complexity of integrating chemoinformatics into existing workflows may also hinder market growth.Data standardization issues, the need for skilled professionals, and concerns about data security and intellectual property protection may hamper the global chemoinformatics market. The high cost of advanced software tools and the complexity of integrating chemoinformatics into existing workflows may also hinder market growth.
The leading players in the global chemoinformatics market include Schrödinger, Inc., Chemical Computing Group ULC, Certara, Inc., ChemAxon Ltd., Molecular Discovery Ltd., and others.
| 1.Executive Summary |
| 2.Global Chemoinformatics Market Introduction |
| 2.1.Global Chemoinformatics Market - Taxonomy |
| 2.2.Global Chemoinformatics Market - Definitions |
| 2.2.1.Tool |
| 2.2.2.Application |
| 2.2.3.End-user |
| 2.2.4.Region |
| 3.Global Chemoinformatics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Chemoinformatics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Chemoinformatics Market By Tool, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Chemical Databases |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Molecular Modeling Software |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. QSAR Software |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Chemoinformatics Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Drug Discovery |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Chemical Analysis |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. QSAR (Quantitative Structure-Activity Relationship) |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Chemoinformatics Market By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Pharmaceutical & Biotechnology Companies |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Academic & Research Institutes |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Chemoinformatics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Chemoinformatics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Tool Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Chemical Databases |
| 9.1.2.Molecular Modeling Software |
| 9.1.3.QSAR Software |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Drug Discovery |
| 9.2.2.Chemical Analysis |
| 9.2.3.QSAR (Quantitative Structure-Activity Relationship) |
| 9.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical & Biotechnology Companies |
| 9.3.2.Academic & Research Institutes |
| 9.3.3.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Chemoinformatics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Tool Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Chemical Databases |
| 10.1.2.Molecular Modeling Software |
| 10.1.3.QSAR Software |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Drug Discovery |
| 10.2.2.Chemical Analysis |
| 10.2.3.QSAR (Quantitative Structure-Activity Relationship) |
| 10.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical & Biotechnology Companies |
| 10.3.2.Academic & Research Institutes |
| 10.3.3.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Chemoinformatics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Tool Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Chemical Databases |
| 11.1.2.Molecular Modeling Software |
| 11.1.3.QSAR Software |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Drug Discovery |
| 11.2.2.Chemical Analysis |
| 11.2.3.QSAR (Quantitative Structure-Activity Relationship) |
| 11.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical & Biotechnology Companies |
| 11.3.2.Academic & Research Institutes |
| 11.3.3.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Chemoinformatics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Tool Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Chemical Databases |
| 12.1.2.Molecular Modeling Software |
| 12.1.3.QSAR Software |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Drug Discovery |
| 12.2.2.Chemical Analysis |
| 12.2.3.QSAR (Quantitative Structure-Activity Relationship) |
| 12.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical & Biotechnology Companies |
| 12.3.2.Academic & Research Institutes |
| 12.3.3.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Chemoinformatics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Tool Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Chemical Databases |
| 13.1.2.Molecular Modeling Software |
| 13.1.3.QSAR Software |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Drug Discovery |
| 13.2.2.Chemical Analysis |
| 13.2.3.QSAR (Quantitative Structure-Activity Relationship) |
| 13.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical & Biotechnology Companies |
| 13.3.2.Academic & Research Institutes |
| 13.3.3.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Schrödinger, Inc. |
| 14.2.2.Chemical Computing Group ULC |
| 14.2.3.Certara, Inc. |
| 14.2.4.ChemAxon Ltd. |
| 14.2.5.Molecular Discovery Ltd. |
| 14.2.6.OpenEye Scientific Software, Inc. |
| 14.2.7.Dassault Systèmes |
| 14.2.8.BIOVIA Corp. |
| 14.2.9.Dotmatics Ltd. |
| 14.2.10.Cresset BioMolecular Discovery Ltd. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.